CA9 and nonpapillary renal cell carcinoma: Using ESP technology, the authors found significant heterogeneity of CTCs in the blood of patients with metastatic ccRCC, which was reflected in the detection of subpopulations of CTCs expressing distinct combinations of the markers CAIX 9, EpCAM, CAXII and CK.